Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 4/20 | 0.42 |
| ▸ | CNR2 | P34972 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20577731 | 0.93 | KMT2A (0.56) | KMT2APOLBP2RX3ALDH1A1KDM4E | |
| SCHEMBL20656546 | 0.89 | TOP1 (0.43) | KMT2APOLBALDH1A1KDM4EHPGD | |
| SCHEMBL20656550 | 0.84 | TDP1 (0.46) | KMT2APOLBP2RX3ALDH1A1CNR1 | |
| SCHEMBL4659798 | 0.82 | KMT2A (0.54) | KMT2APOLBP2RX3ALDH1A1KDM4E | |
| SCHEMBL17775886 | 0.81 | P2RX3 (0.60) | KMT2APOLBP2RX3ALDH1A1KDM4E | |
| SCHEMBL20577690 | 0.81 | ALDH1A1 (0.45) | KMT2APOLBALDH1A1KDM4EHPGD | |
| SCHEMBL7035140 | 0.81 | KMT2A (0.57) | KMT2APOLBP2RX3ALDH1A1KDM4E | |
| SCHEMBL15282075 | 0.80 | KMT2A (0.59) | KMT2APOLBP2RX3ALDH1A1KDM4E | |
| SCHEMBL7041173 | 0.80 | KMT2A (0.56) | KMT2APOLBP2RX3ALDH1A1KDM4E | |
| SCHEMBL11067835 | 0.80 | KMT2A (0.60) | KMT2APOLBP2RX3ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2644596-B1 | HAPTENS AND IMMUNOREACTIVE AGENTS AND USE THEREOF FOR PRODUCING FAMILY ANTIBODIES AND IMMUNOASSAYS FOR QUINOLONES | CONSEJO SUPERIOR INVESTIGACION (ES) | 2019-01-23 | — | — | EP | claimed |
| EP-2644596-B1 | HAPTENS AND IMMUNOREACTIVE AGENTS AND USE THEREOF FOR PRODUCING FAMILY ANTIBODIES AND IMMUNOASSAYS FOR QUINOLONES | CONSEJO SUPERIOR INVESTIGACION (ES) | 2019-01-23 | — | — | EP | disclosed |
| US-10150736-B2 | Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2018-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10150736-B2 | Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones | NQO2, NISCH, VIP | KMT2A 2527/4885POLB 3704/4885P2RX3 574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.